Financhill
Back

Teva Pharmaceutical Industries 10K Form

Sell
36

TEVA
Teva Pharmaceutical Industries

Last Price:
17.03
Seasonality Move:
10.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive TEVA News And Ratings

See the #1 stock for the next 7 days that we like better than TEVA

TEVA Financial Statistics

Sales & Book Value

Annual Sales: $15.85B
Cash Flow: $545M
Price / Cash Flow: 13.59
Annual Sales: $5.35
Price / Book: 3.08

Profitability

EPS (TTM): -0.85000
Net Income (TTM): $-959M
Gross Margin: $7.65B
Return on Equity: -13.27%
Return on Assets: -2.27%

Teva Pharmaceutical Industries Earnings Forecast

Key Teva Pharmaceutical Industries Financial Ratios

  • The Gross Profit Margin over the past 38 years for TEVA is 48.25%.
  • The Selling, General & Administrative Expenses for TEVA have been equal to 22.08% of Gross Profit Margin.
  • The Research & Development expenses have been 6.01% of Revenue.
  • The Interest Expense is -184.08% of Operating Income.
  • The Net Earning history of TEVA is -3.53% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 21 years.

Teva Pharmaceutical Industries Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TEVA
CUSIP: 881624
Website: tevapharm.com

Debt

Debt-to-Equity Ratio: 3.13
Current Ratio: 0.89
Quick Ratio: 0.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 5.93

TEVA Technical Analysis vs Fundamental Analysis

Sell
36
Teva Pharmaceutical Industries (TEVA) is a Sell

Is Teva Pharmaceutical Industries a Buy or a Sell?